Final results of ARIEL2 (Part 1): A phase 2 trial to prospectively identify ovarian cancer (OC) responders to rucaparib using tumor genetic analysis
- Authors:
- R Kristeleit, E Swisher, A Oza, RL Coleman, C Scott, G Konecny, A Tinker, DM O'Malley, J Brenton, K Bell-McGuinn, A Oaknin, A Leary, KK Lin, M Raponi, H Giordano, L Maloney, S Goble, R Yelensky, I McNeish
- Journal:
- EUROPEAN JOURNAL OF CANCER
- Citation info:
- 51:S531-S531
- Publication date:
- 1st Aug 2015
- Full text
- DOI